Alexander Shiferson, DO
Vascular Surgery · Brooklyn, NYNPI 1427278407
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $14,515 with a category attached, or 68.9%. Boston Scientific accounts for 73.0% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $6,471, 5.8 times the $1,113 reported in 2019.
Across 177 payments — averaging $82.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Tactile Systems Technology Inc$2K
- Cook Medical LLC$508
- W. L. Gore & Associates, Inc.$446
- Medtronic$279
- Baxter Healthcare$226
- plus $900 from 20 others
What the payments were for
- Speaking & faculty fees$10,00069%
- Travel & lodging$490%
- Food & beverage$4,46631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $10,600 |
| Tactile Systems Technology Inc | 108 | $1,556 |
| Cook Medical LLC | 11 | $508 |
| W. L. Gore & Associates, Inc. | 8 | $446 |
| Medtronic(2 entities) | 7 | $279 |
| Baxter Healthcare | 3 | $226 |
| Abbott | 2 | $174 |
| Bolton Medical Inc | 1 | $130 |
| Terumo Medical Corporation | 3 | $65 |
| Innovation Technologies Inc | 1 | $58 |
| Organogenesis Inc. | 2 | $58 |
| Bard Peripheral Vascular, Inc. | 2 | $55 |
| Stryker | 2 | $49 |
| Johnson & Johnson | 1 | $47 |
| Argon Medical Devices, Inc. | 3 | $41 |
| Shockwave Medical, Inc | 1 | $33 |
| Lemaitre Vascular, Inc. | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $24 |
| Angiodynamics, Inc. | 1 | $23 |
| Advanced Oxygen Therapy Inc. | 1 | $21 |
| Endologix LLC | 1 | $20 |
| Acera Surgical, Inc. | 1 | $19 |
| Inari Medical, Inc. | 1 | $16 |
| Sirtex Medical Inc | 1 | $15 |
| Smith+Nephew | 1 | $13 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,515 in reported general payments places this provider in the 70th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 19 | $33 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Brooklyn
- Robert RheeBrooklyn$338K
- Nicole IlonzoBrooklyn$94K
- Michael ShapiroBrooklyn$54K
- William LoisBrooklyn$39K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.5M
- Sonya NoorBuffalo$991K
- John LantisNew York$922K
- Brian DerubertisNew York$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.